RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Nephrology | Brick, NJ | $74.00 | 3 |
| , M.D | Nephrology | Tullahoma, TN | $74.00 | 4 |
| , MD | Nephrology | Brick, NJ | $73.41 | 3 |
| , M.D | Nephrology | Belleville, NJ | $73.00 | 4 |
| , MD | Nephrology | Memphis, TN | $72.95 | 5 |
| , M.D | Nephrology | Greenbelt, MD | $72.83 | 4 |
| , M.D | Nephrology | Greenbelt, MD | $72.83 | 4 |
| , MD | Nephrology | San Antonio, TX | $72.59 | 5 |
| , M.D | Nephrology | North Charleston, SC | $72.45 | 4 |
| , MD | Nephrology | Richmond, VA | $72.43 | 4 |
| , M.D | Internal Medicine | West Orange, NJ | $72.38 | 4 |
| Ilya Shneyderman | Nephrology | Brooklyn, NY | $72.07 | 3 |
| , MD | Nephrology | Houston, TX | $72.06 | 3 |
| , M.D | Nephrology | Warren, MI | $71.68 | 4 |
| , MD | Nephrology | Washington, DC | $71.43 | 3 |
| , MD | Nephrology | Brick, NJ | $70.73 | 3 |
| , M.D | Nephrology | Little Rock, AR | $70.31 | 4 |
| , MD | Internal Medicine | Eatontown, NJ | $70.00 | 3 |
| , MD | Nephrology | Lafayette, IN | $69.33 | 3 |
| , MD | Nephrology | Brick, NJ | $69.25 | 3 |
| , M.D | Nephrology | San Jose, CA | $69.21 | 4 |
| , DO | Nephrology | Philadelphia, PA | $68.49 | 3 |
| , MD FACP FASN | Nephrology | Houston, TX | $68.46 | 3 |
| , D.O | Internal Medicine | Huntsville, AL | $68.15 | 4 |
| , MD | Nephrology | New Hyde Park, NY | $68.01 | 4 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).